2022
DOI: 10.21037/tlcr-22-311
|View full text |Cite
|
Sign up to set email alerts
|

NLRP3 activation in tumor-associated macrophages enhances lung metastasis of pancreatic ductal adenocarcinoma

Abstract: Background: Pancreatic ductal adenocarcinoma (PDAC) is the most common type of pancreatic cancer and is highly malignant due to its late diagnosis and early metastasis. Lung metastasis of PDAC occurs in a significant number of diagnosed patients and represents high severity of disease and poor clinical outcome.However, the molecular regulation of lung metastasis of PDAC is still not fully understood. Tumorassociated macrophages (TAMs) have recently been found to play an important role in cancer initiation, pro… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
10
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 13 publications
(10 citation statements)
references
References 24 publications
0
10
0
Order By: Relevance
“…Analysis of prognosis has revealed a lower survival rate in patients with LUAD who exhibit low expression levels of NLRP7, NLRP1, NLRP2 and nucleotide binding oligomerization domain containing 1, as well as high expression levels of caspase-6 ( 17 ). Additionally, activation of the NLRP3 inflammasome has been shown to accelerate the progression of LUAD by promoting the proliferation and metastasis of lung cancer cells ( 18 ). Conversely, downregulation of GSDMD has been demonstrated to mitigate tumor proliferation via the intrinsic mitochondrial apoptotic pathway, as well as through inhibition of EGFR/Akt signaling, and is associated with favorable prognostic outcomes in LUAD ( 19 , 20 ).…”
Section: Discussionmentioning
confidence: 99%
“…Analysis of prognosis has revealed a lower survival rate in patients with LUAD who exhibit low expression levels of NLRP7, NLRP1, NLRP2 and nucleotide binding oligomerization domain containing 1, as well as high expression levels of caspase-6 ( 17 ). Additionally, activation of the NLRP3 inflammasome has been shown to accelerate the progression of LUAD by promoting the proliferation and metastasis of lung cancer cells ( 18 ). Conversely, downregulation of GSDMD has been demonstrated to mitigate tumor proliferation via the intrinsic mitochondrial apoptotic pathway, as well as through inhibition of EGFR/Akt signaling, and is associated with favorable prognostic outcomes in LUAD ( 19 , 20 ).…”
Section: Discussionmentioning
confidence: 99%
“…According to previous reports, cells with CASP8 mutations are resistant to exogenous agents that induce cell apoptosis, which can prevent the killing of tumor cells by T cells through FasL-Fas interactions, which is one of the immune evasion mechanisms of tumors [32,33]. The NLRP3 inflammasome is a key component of the innate immune system, and depletion of NLRP3 in macrophages is beneficial for M1/M2b polarization [34]. NLRP3 depletion significantly inhibited tumor growth and stage progression, and it also significantly reduced the occurrence of pancreatic ductal adenocarcinoma (PDAC) lung metastasis [34].…”
Section: Discussionmentioning
confidence: 99%
“…The NLRP3 inflammasome is a key component of the innate immune system, and depletion of NLRP3 in macrophages is beneficial for M1/M2b polarization [34]. NLRP3 depletion significantly inhibited tumor growth and stage progression, and it also significantly reduced the occurrence of pancreatic ductal adenocarcinoma (PDAC) lung metastasis [34]. Methylation level was most closely related to survival in LGG and ACC.…”
Section: Discussionmentioning
confidence: 99%
“…In addition, TAMs can promote tumor cell metastasis and induce therapeutic resistance. For example, NLR family pyrin domain containing 3 (NLRP3) activation induced the M2-like macrophage polarization of TAMs in a murine model of PDAC to promote cancer cell lung metastasis [78]. Therefore, targeting TAMs and their associated factors can improve PDAC therapy.…”
Section: Tumor-associated Macrophages (Tams)mentioning
confidence: 99%